Storys zum Thema Medizin, Gesundheit

SIFI Press & Communication Office

SIFI appoints Jelle Kleijn as Global Head of Acanthamoeba Keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection

Catania, Italy (ots/PRNewswire) - Given urgency to treat, SIFI has established a dedicated cross-functional team to accelerate the launch of polihexanide monotherapy in Europe and the United States. SIFI, a leading ophthalmic company, is pleased to announce the recent appointment of Jelle Kleijn, PhD, as Global Head ...

BD (Becton, Dickinson and Company)

BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years

Franklin Lakes, N.j. (ots/PRNewswire) - - Investment includes new manufacturing facility in Europe BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and ...

Norgine

Norgine B.V. Announces New European Healthcare Subsidiary To Strengthen Its Consumer Healthcare Portfolio

Amsterdam, The Netherlands (ots/PRNewswire) - Norgine B.V. ("Norgine"), today announced the establishment of a wholly-owned subsidiary, Norgine Healthcare B.V. ("Norgine Healthcare"), which will be dedicated to consumer healthcare. To view the Multimedia News Release, please click: ...

Merck Healthcare Germany GmbH

European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations

Darmstadt, Germany (ots/PRNewswire) - Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial ...

Helsana Gruppe

Helsana Drug Report: Spitex patients exposed to significant medication risks

Zurich (ots) - In 2019, medication costs in Switzerland totalled approximately CHF 7.6 billion. The front runners remained cancer and immune system drugs, followed by nervous system medications and metabolic preparations. The use of biosimilars (generic preparations) offers significant savings potential that unfortunately remains almost completely unexploited. In an ...

Fresenius Kabi Deutschland GmbH

Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition

BAD HOMBURG (ots) - Evidence indicates that omega-3 (?-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,1 underlining its role in today's hospitals and clinics. To support continuous health care professional (HCP) education on omega-3 fatty ...

Zentiva

Zentiva Continues Its Planet-Z Program For A Healthier Planet By Planting 4,500 Trees In Portugal

Prague (ots/PRNewswire) - Zentiva Group will plant 4,500 new trees as part of its PlanetZ program which aims to make a continuous and positive contribution to our environment. Zentiva is collaborating with the Associação Nacional de Empresas Florestais, Agrícolas e do Ambiente (ANEFA), an NGO in Portugal, to make it happen. The trees will be planted in Baldio do ...

GH Research Ltd

GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress

Dublin (ots/PRNewswire) - GH Research Limited ("GH Research" or "the Company") today announced the successful completion of a Phase 1 clinical study with GH001 in healthy volunteers. The Company is currently recruiting for a Phase 1/2 clinical study with GH001 in patients with Treatment-Resistant Depression. GH ...

Sanitation and Hygiene Fund

Global leaders welcome the Sanitation and Hygiene Fund as key to increasing investment

Geneva (ots/PRNewswire) - The Sanitation and Hygiene Fund will be critical to dramatically scale up investments to reach everyone with sanitation services, United Nations Deputy Secretary-General has said as the new financial mechanism to drive billions of dollars into the sanitation sector was launched today. Speaking at the launch of the new Sanitation and Hygiene ...

Sanitation and Hygiene Fund

3

Global leaders welcome the Sanitation and Hygiene Fund as key to increasing investment

Sophia Genetics

Bram Goorden joins SOPHiA GENETICS as Chief Commercial Officer and Head of North America

Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Bram Goorden joined its Executive team, holding the dual role of Chief Commercial Officer and Head of North America. Goorden comes to SOPHiA from Foundation Medicine Inc. (Cambridge, MA) where he held the role of VP of International Business and ...

FDI World Dental Federation

Study shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year

ForaCare Suisse AG

FORA® 6 Blood Glucose Monitors Help Diabetic Patients Monitor COVID-19 Risks

Sanitation and Hygiene Fund

2

The Sanitation and Hygiene Fund to be launched on 17 November

Swiss Rockets AG

Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine

Merck Healthcare Germany GmbH

Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics

Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up to EUR 605 million in development ...

OrbusNeich

OrbusNeich® Medical and P+F Products & Features® announce new partnership

Hong Kong (ots/PRNewswire) - Introducing a new portfolio of heart valve products aiming to restore health and extend life OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive heart valve products in the Asia Pacific region, including China, Japan, Taiwan, ...

Magnostics Ltd

Magnostics is Co-Developing and Launching a Viral RNA Extraction Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR

Dublin (ots/PRNewswire) - Magnostics is leading a consortium of University and National Researchers to develop and launch Viral RNA Extraction Kits for detection of COVID-19. A team of scientist from Saint Vincent University Hospital, National Virus Reference Laboratory, University College Dublin, and Magnostics ...

Novo Nordisk

Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy

Bagsværd, Denmark (ots/PRNewswire) - Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STEP 3 phase 3a trial investigated ...

Avectas

Avectas Opens Canadian Development Site

Dublin (ots/PRNewswire) - - Avectas announces residency at Johnson & Johnson Innovation - JLABS @ Toronto, central to the Canadian bio-hub. - Jessica Schwaber, PhD appointed Scientific Director of Cell and Gene Therapy. Avectas, a cell engineering technology business, is pleased to announce it has been accepted to become a resident at Johnson & Johnson Innovation - JLABS @ Toronto. JLABS @ Toronto is a 40,000 square-foot ...

EvoBiotiX

EvoBiotiX collaborates with Boehringer Ingelheim and the University of Salzburg on naturally derived Extracellular Vesicles (EVs)

Salzburg/Melide(CH) (ots) - Swiss Biotech EvoBiotiX SA today announced a multi-year collaboration with Boehringer Ingelheim in the field of naturally derived EVs. A significant part of this program will fund research of the drug delivery potential of naturally derived EVs in the group of Prof. Meisner-Kober at the ...

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - A Second Wave of Coronavirus Threatens the Swiss Labor Market

RARECELLS DIAGNOSTICS

ISET® test results show substantial improvement in early detection of prostate cancer by identifying PSA-positive Circulating Tumor Cells

Paris (ots/PRNewswire) - Rarecells, Inc. (USA), a leading Liquid Biopsy company, is pleased to announce that National Institute of Integrative Medicine's (Melbourne, Australia) researchers obtained striking results in a group of Australian men using the ISET® test for early prostate cancer diagnosis through the ...

China Matters

China Matters presents Documentary on 42,000 Portraits of COVID-19 Frontline Workers in Wuhan

Euroclear Holding, Euroclear Investments, Euroclear SA/NV

Euroclear Business and Financial update - Q3 2020

Brussels (ots/PRNewswire) - Financial Highlights - Year-to-date (Q3 YTD) 2020 revenues down 3% year-on-year, to EUR 1057 million. - Q3 YTD Business Income increased 12% to EUR 951 million, driven by favourable market conditions and implementation of strategic initiatives Q3 YTD Banking and Other Income decreased 55% to EUR 106 million as a result of interest rate cuts - Q3 YTD Operating costs up 3% to EUR 637 million, in ...

FDI World Dental Federation

FDI World Dental Federation says Be Proud of Your Mouth for World Oral Health Day 2021 to 2023

The International Osteoporosis Foundation (IOF)

One broken bone leads to another, warns IOF on World Osteoporosis Day

Zentiva

Zentiva Reinforces Its Presence In Greece To Better Serve Greek People

Prague (ots/PRNewswire) - Zentiva reinforces its presence in Greece by signing a partnership with the company Lavipharm for representation, promotion, and distribution of its pharmaceutical products in Greece. With an established presence in Europe, Zentiva continues to strengthen its capabilities and service offering for people, by partnering with Lavipharm. "We are ...

Servier

Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

Mechelen, Belgium and Paris (ots/PRNewswire) - Servier and Galapagos NV report that no signal of activity was observed in the topline results in their ROCCELLA Phase 2 trial with GLPG1972/S201086. ROCCELLA is a global, double-blind, placebo-controlled, dose ranging trial evaluating the efficacy and safety of three ...

International Center for Journalists (ICFJ); Tow Center for Digital Journalism at Columbia University

New Global Survey Raises Red Flags for Journalism in the COVID-19 Era

London (ots/PRNewswire) - Results launched today by International Center for Journalists (ICFJ) and Tow Center for Digital Journalism at Columbia University Facing everything from a barrage of disinformation to heightened security risks and a mental health crisis, journalists around the world are contending with myriad daunting challenges as they report on a deadly pandemic, according to the first results from a global ...